For the secondary outcomes , @ % in the drug group and @ % in the ablation group experienced the first recurrence of symptomatic AF , atrial flutter , atrial tachycardia ( HR , @ -LSB- @ % CI , @-@ @ -RSB- ; P = @ ) .